Advertisement
UK markets close in 8 hours 10 minutes
  • FTSE 100

    8,073.95
    +29.14 (+0.36%)
     
  • FTSE 250

    19,801.37
    +1.65 (+0.01%)
     
  • AIM

    756.44
    +1.57 (+0.21%)
     
  • GBP/EUR

    1.1627
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2435
    -0.0018 (-0.14%)
     
  • Bitcoin GBP

    53,786.65
    +398.21 (+0.75%)
     
  • CMC Crypto 200

    1,417.34
    -6.76 (-0.47%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.45
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,335.30
    -6.80 (-0.29%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,202.54
    +373.61 (+2.22%)
     
  • DAX

    18,183.99
    +46.34 (+0.26%)
     
  • CAC 40

    8,105.69
    -0.09 (-0.00%)
     

Trelegy Ellipta May Emerge as Major Growth Driver for GlaxoSmithKline

Trelegy Ellipta May Emerge as Major Growth Driver for GlaxoSmithKline

A Look at GlaxoSmithKline's Growth Drivers in 2018FDA approval of Trelegy Ellipta